|
|||||
|
|
A second-site revertant of a defective herpes simplex virus ICP4 protein with restored regulatory activities and impaired DNA-binding properties. |
|
| Authors: | A A Shepard and N A DeLuca |
| Affiliation: | Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115. |
| Abstract: | |
| Keywords: | |